HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanofi

This article was originally published in The Rose Sheet

Executive Summary

Beauty business sales increased 9.7% to approximately $294.6 mil. (FFr 1.7 bil.) on constant exchange rates for the first half, boosted by Yves Saint Laurent and the worldwide launch of So de la Renta, the company reported Sept. 2. Due to price improvements, the beauty division recorded an operating profit of about $6.8 mil. (FFr 39 mil.), compared to an operating loss of nearly $5.4 mil. (FFr 31 mil.) in the first half of 1997. The company as a whole registered sales of $2.23 bil. (FFr 12.9 bil.), a 6.5% increase over the same period last year. During the half, Sanofi's capital gains totaled approximately $14.4 mil. (FFr 83 mil.), due in part to the sale of the Nina Ricci brand to Puig, completed Jan. 8 ("The Rose Sheet" Feb. 16, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005808

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel